News
Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
4h
Zacks.com on MSNJ&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal?JNJ eyes $50B in oncology sales by 2030, driven by drugs like Darzalex, Erleada, new launches including Carvykti and Tecvayli, and its cancer pipeline.
10h
GlobalData on MSNCan rare disease research in the US thrive under the new administration?As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.
19h
BabyCenter on MSNIs it safe to get vaccinated during pregnancy?Find out which vaccines are recommended while you're pregnant to protect you and your baby, and which you'll need to wait on.
The agreement, signed Monday between CMS and DHS, has not been announced publicly, AP reports. Other Trump administration ...
Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy appeared at risk.
The agreement allows manufacturers to develop, manufacture and supply generic long-acting injectable cabotegravir for treatment in 133 countries.
An FDA advisory committee ruled in two separate votes that two belantamab mafodotin combination regimens should not be used ...
Market OutlineThe Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to ...
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results